文献速递痛风与晶体性关节病

超声识别焦磷酸钙沉积病(CPPD):OMERACT定义在扩展关节集中的可靠性——OMERACT焦磷酸钙沉积病超声亚组的一项国际多观察者研究

Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints-an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force.
PubMed 文献 · Ann Rheum Dis · 2018-03-13

该国际多观察者研究评估了OMERACT超声定义在掌指关节、腕三角纤维软骨(TFC)、肩锁(AC)和髋关节识别CPPD的可靠性。基于网络和基于患者的练习显示,TFC和AC的观察者间和观察者内kappa值较高或可接受,而其他部位在网络练习中kappa值良好但在患者练习中未能达到良好可重复性,扫描方法需进一步改进。

要点

  • OMERACT超声定义在TFC和AC关节识别CPPD可靠。
  • TFC的观察者间和观察者内kappa值范围为0.75至0.87。
  • AC的kappa值范围为0.51至0.85,可用于超声CPPD识别。

核心结论

  • OMERACT超声定义应用于TFC和AC时被证明是可靠的。
  • 其他部位在网络练习中达到良好kappa值,但在患者练习中未能达到良好可重复性,意味着扫描方法必须进一步改进。

研究设计与样本

  • 开展了一项基于网络的练习和随后的基于患者的练习。
  • 30名OMERACT成员参与网络练习,通过两次评估一组超声图像判断CPPD存在/缺失。
  • 19名成员在意大利锡耶纳进行基于患者的练习,所有超声检查者对8名患者同一组关节进行两次检查以判断CPPD存在/缺失。
  • 计算了两种练习的观察者内和观察者间kappa值。

主要发现

  • 网络练习在所有部位的观察者内和观察者间评估中均获得高kappa值。
  • 在患者练习中,TFC和AC的观察者间一致性可接受。
  • TFC在两种练习中均达到高观察者间和观察者内kappa值,范围为0.75至0.87(良好至优秀一致性)。
  • AC达到中等kappa值,范围为0.51至0.85(中等至优秀一致性),可随时用于超声CPPD识别。

关键数值与推荐

  • TFC的观察者间和观察者内kappa值范围为0.75至0.87(良好至优秀一致性)。
  • AC的kappa值范围为0.51至0.85(中等至优秀一致性)。

临床怎么用

  • OMERACT超声定义在应用于TFC和AC时可靠,可用于超声识别CPPD。
  • 其他部位的扫描方法必须进一步改进。

局限性

  • 其他部位在网络练习中达到良好kappa值但在患者练习中未能达到良好可重复性,意味着扫描方法必须进一步改进。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To assess the reliability of the OMERACT ultrasound (US) definitions for the identification of calcium pyrophosphate deposition disease (CPPD) at the metacarpal-phalangeal, triangular fibrocartilage of the wrist (TFC), acromioclavicular (AC) and hip joints. METHODS: A web-based exercise and subsequent patient-based exercise were carried out. A panel of 30 OMERACT members, participated at the web-based exercise by evaluating twice a set of US images for the presence/absence of CPPD. Afterwards, 19 members of the panel met in Siena, Italy, for the patient-based exercise. During the exercise, all sonographers examined twice eight patients for the presence/absence of CPPD at the same joints. Intraoberserver and interobserver kappa values were calculated for both exercises. RESULTS: The web-based exercise yielded high kappa values both in intraobserver and interobserver evaluation for all sites, while in the patient-based exercise, inter-reader agreement was acceptable for the TFC and the AC. TFC reached high interobserver and intraobserver k values in both exercises, ranging from 0.75 to 0.87 (good to excellent agreement). AC reached moderate kappa values, from 0.51 to 0.85 (moderate to excellent agreement) and can readily be used for US CPPD identification. CONCLUSIONS: Based on the results of our exercise, the OMERACT US definitions for the identification of CPPD demonstrated to be reliable when applied to the TFC and AC. Other sites reached good kappa values in the web-based exercise but failed to achieve good reproducibility at the patient-based exercise, meaning the scanning method must be further refined.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. Filippou G, Scirè CA, Adinolfi A, et al. Identification of calcium pyrophosphate deposition disease (CPPD) by ultrasound: reliability of the OMERACT definitions in an extended set of joints-an international multiobserver study by the OMERACT Calcium Pyrophosphate Deposition Disease Ultrasound Subtask Force. Ann Rheum Dis. 2018. PMID: 29535120. doi:10.1136/annrheumdis-2017-212542

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。